Clinical Trial Update: Bortezomib With Melphalan and Prednisone for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating bortezomib with melphalan and prednisone for multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Duke University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2013-05-31